Loading...

Laura Esserman, MD

Title(s)Professor, Surgery
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-885-7691
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Laura Esserman, M.D., M.B.A is a surgeon and breast cancer oncology specialist practicing at the UCSF Carol Franc Buck Breast Care Center where she has also held the position of Director since 1996. She co-leads the Breast Oncology Program, the largest of the UCSF Helen Diller Comprehensive Cancer Center's multidisciplinary programs. The program is comprised of 69 faculty members who represent 16 academic specialties and is internationally recognized and well-established with major initiatives in epidemiology, genetics, biology, therapeutics, and clinical cancer care. She is a professor of Surgery & Radiology at UCSF and faculty at the UCSF Helen Diller Family Comprehensive Cancer Center where she founded the program in Translational Informatics. As part of this program, her research has focused on bioinformatics, medical and clinical informatics, systems integration, and clinical care delivery.

    She has worked at UCSF to develop interdisciplinary teams of clinicians and researchers to bring the best care to patients and find the best platform to integrate translational research and improve the delivery of breast cancer care. In 2005, she received the NCI SPORE Investigator of the Year Award, an internationally recognized honor and designation.

    She is the Principle Investigator of the I-SPY TRIAL program, a multi-site neoadjuvant clinical trial that has evolved into a model for translational research and innovation in clinical trial design.

    Dr. Esserman has recently launched a University of California-wide breast cancer initiative called the Athena Breast Health Network, a project designed to follow 400,000 women from screening through treatment and outcomes, incorporating the latest in molecular testing and web-based tools into the course of care.

    Dr. Esserman is nationally and internationally known as a leader in the field of breast cancer and has published over 150 articles in peer-reviewed journals covering all aspects of breast health including information systems, immunology, decision making, health policy and the use of imaging. She speaks extensively at public and private forums within the U.S. and internationally. Overall, Dr. Esserman's research and writing tends to focus on the goal of giving patients better access to accurate information so that they can become partners in their health care.

    She is a member of President Obama’s Council of Advisors on Science and Technology (PCAST) Working Group on Advancing Innovation in Drug Development and Evaluation, which is studying how the federal government can best support science-based innovation in the process of drug development and regulatory evaluation. In addition, she is a contributing member of a “taskforce” for President Obama’s Council of Advisors on Science and Technology.

    Dr. Esserman received her Bachelor's degree in History of Science from Harvard University and completed her M.D. at Stanford University. She completed her surgery residency and oncology fellowship at Stanford University Medical Center. After her training, she joined the faculty at Stanford and received a Hartford fellowship to attend Stanford Business School where she received her M.B.A. in 1993. She then joined the faculty at the University of California, San Francisco.

    Collapse Research 
    Collapse Research Activities and Funding
    Surgical Oncology Training Grant
    NIH/NCI T32CA251070Jul 15, 2020 - Jun 30, 2025
    Role: Principal Investigator
    Extending the Diversity, Reach, and Generalizability of the WISDOM Study
    NIH/NCI R01CA237533Mar 1, 2020 - Feb 28, 2025
    Role: Principal Investigator
    I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
    NIH/NCI P01CA210961Sep 8, 2017 - Aug 31, 2022
    Role: Principal Investigator
    Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers
    NIH/NCI U01CA196406Sep 16, 2015 - Aug 31, 2020
    Role: Principal Investigator
    Modeling the Impact of Targeted Therapy Based on Breast Cancer Subtypes
    NIH/NCI U01CA187945Sep 18, 2014 - Aug 31, 2019
    Role: Principal Investigator
    Integrated Biomarkers to Characterize Breast Cancer Risk
    NIH/NCI U01CA111234Sep 20, 2004 - Jun 30, 2011
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites
    Collapse In The News
    Collapse Student Projects
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The Evolution of Our Understanding of the Biology of Cancer Is the Key to Avoiding Overdiagnosis and Overtreatment. Cancer Epidemiol Biomarkers Prev. 2020 Oct 08. Esserman LJ, Hewitt K, Son J, Glencer A, Borowsky AD, Cooperberg MR. PMID: 33033145.
      View in: PubMed   Mentions:    Fields:    
    2. Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience. Ann Surg Oncol. 2020 Oct 06. Son JD, Piper M, Hewitt K, Alvarado M, Esserman LJ, Ewing C, Wong JM, Mukhtar RA. PMID: 33025355.
      View in: PubMed   Mentions:    Fields:    
    3. Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective. Surgery. 2020 Oct; 168(4):601-609. Sharib J, Esserman L, Koay EJ, Maitra A, Shen Y, Kirkwood KS, Ozanne EM. PMID: 32739138.
      View in: PubMed   Mentions:    Fields:    
    4. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 Jul 23. Yee D, DeMichele AM, Yau C, Isaacs C, Symmans WF, Albain KS, Chen YY, Krings G, Wei S, Harada S, Datnow B, Fadare O, Klein M, Pambuccian S, Chen B, Adamson K, Sams S, Mhawech-Fauceglia P, Magliocco A, Feldman M, Rendi M, Sattar H, Zeck J, Ocal IT, Tawfik O, LeBeau LG, Sahoo S, Vinh T, Chien AJ, Forero-Torres A, Stringer-Reasor E, Wallace AM, Pusztai L, Boughey JC, Ellis ED, Elias AD, Lu J, Lang JE, Han HS, Clark AS, Nanda R, Northfelt DW, Khan QJ, Viscusi RK, Euhus DM, Edmiston KK, Chui SY, Kemmer K, Park JW, Liu MC, Olopade O, Leyland-Jones B, Tripathy D, Moulder SL, Rugo HS, Schwab R, Lo S, Helsten T, Beckwith H, Haugen P, Hylton NM, Van't Veer LJ, Perlmutter J, Melisko ME, Wilson A, Peterson G, Asare AL, Buxton MB, Paoloni M, Clennell JL, Hirst GL, Singhrao R, Steeg K, Matthews JB, Asare SM, Sanil A, Berry SM, Esserman LJ, Berry DA. PMID: 32701140.
      View in: PubMed   Mentions:    Fields:    
    5. Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- Patients. J Breast Imaging. 2020 Aug; 2(4):352-360. Arasu VA, Kim P, Li W, Strand F, McHargue C, Harnish R, Newitt DC, Jones EF, Glymour MM, Kornak J, Esserman LJ, Hylton NM. PMID: 32803155.
      View in: PubMed   Mentions:
    6. Evaluating the impact of axillary dissection on recurrence-free survival by extent of nodal disease in invasive lobular carcinoma of the breast. Breast Cancer Res Treat. 2020 Oct; 183(3):661-667. Abel MK, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Park C, Mukhtar RA. PMID: 32696313.
      View in: PubMed   Mentions:    Fields:    
    7. Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol. 2020 Jun 29. Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, Sroczynski G, Hall P, Cuzick J, Evans DG, Simard J, Garcia-Closas M, Schmutzler R, Wegwarth O, Pharoah P, Moorthie S, De Montgolfier S, Baron C, Herceg Z, Turnbull C, Balleyguier C, Rossi PG, Wesseling J, Ritchie D, Tischkowitz M, Broeders M, Reisel D, Metspalu A, Callender T, de Koning H, Devilee P, Delaloge S, Schmidt MK, Widschwendter M. PMID: 32601456.
      View in: PubMed   Mentions:    Fields:    
    8. Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater. Am J Surg. 2020 Jun 19. Abel MK, Brabham CE, Guo R, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Mukhtar RA. PMID: 32622509.
      View in: PubMed   Mentions:    Fields:    
    9. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol. 2020 Jun 18. Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, French D, Sroczynski G, Hall P, Cuzick J, Evans DG, Simard J, Garcia-Closas M, Schmutzler R, Wegwarth O, Pharoah P, Moorthie S, De Montgolfier S, Baron C, Herceg Z, Turnbull C, Balleyguier C, Rossi PG, Wesseling J, Ritchie D, Tischkowitz M, Broeders M, Reisel D, Metspalu A, Callender T, de Koning H, Devilee P, Delaloge S, Schmidt MK, Widschwendter M. PMID: 32555420.
      View in: PubMed   Mentions: 1     Fields:    
    10. Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy. Cancers (Basel). 2020 Jun 09; 12(6). Jones EF, Hathi DK, Freimanis R, Mukhtar RA, Chien AJ, Esserman LJ, Van't Veer LJ, Joe BN, Hylton NM. PMID: 32527022.
      View in: PubMed   Mentions:
    11. Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial. Tomography. 2020 06; 6(2):77-85. Onishi N, Li W, Gibbs J, Wilmes LJ, Nguyen A, Jones EF, Arasu V, Kornak J, Joe BN, Esserman LJ, Newitt DC, Hylton NM. PMID: 32548283.
      View in: PubMed   Mentions: 1     Fields:    
    12. Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant Therapy. Tomography. 2020 06; 6(2):101-110. Nguyen AA, Arasu VA, Strand F, Li W, Onishi N, Gibbs J, Jones EF, Joe BN, Esserman LJ, Newitt DC, Hylton NM. PMID: 32548286.
      View in: PubMed   Mentions: 1     Fields:    
    13. Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer. Tomography. 2020 06; 6(2):216-222. Li W, Newitt DC, Yun B, Jones EF, Arasu V, Wilmes LJ, Gibbs J, Nguyen AA, Onishi N, Kornak J, Joe BN, Esserman LJ, Hylton NM. PMID: 32548299.
      View in: PubMed   Mentions: 1     Fields:    
    14. Personalization of Treatment is the Way Forward in Care and Trials. Clin Cancer Res. 2020 Jun 15; 26(12):2771-2773. Esserman LJ. PMID: 32265219.
      View in: PubMed   Mentions:    Fields:    
    15. Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival. Breast Cancer Res Treat. 2020 May; 181(1):23-29. Mukhtar RA, Krings G, Chen YY, Mamounas ME, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Rugo H. PMID: 32240457.
      View in: PubMed   Mentions:    Fields:    
    16. Response to Carter et al. JNCI Cancer Spectr. 2020 Apr; 4(2):pkaa016. Eklund M, Broglio K, Yau C, Connor JT, Fiscalini AS, Esserman LJ. PMID: 32373780.
      View in: PubMed   Mentions:
    17. Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). J Clin Oncol. 2020 Apr 20; 38(12):1284-1292. Hwang ES, Hyslop T, Hendrix LH, Duong S, Bedrosian I, Price E, Caudle A, Hieken T, Guenther J, Hudis CA, Winer E, Lyss AP, Dickson-Witmer D, Hoefer R, Ollila DW, Hardman T, Marks J, Chen YY, Krings G, Esserman L, Hylton N. PMID: 32125937.
      View in: PubMed   Mentions: 4     Fields:    
    18. We need more evidence to answer questions about screening. Nature. 2020 03; 579(7800):S5. Esserman L. PMID: 32214260.
      View in: PubMed   Mentions:    Fields:    
    19. Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial. JAMA Oncol. 2020 Feb 13. Nanda R, Liu MC, Yau C, Shatsky R, Pusztai L, Wallace A, Chien AJ, Forero-Torres A, Ellis E, Han H, Clark A, Albain K, Boughey JC, Jaskowiak NT, Elias A, Isaacs C, Kemmer K, Helsten T, Majure M, Stringer-Reasor E, Parker C, Lee MC, Haddad T, Cohen RN, Asare S, Wilson A, Hirst GL, Singhrao R, Steeg K, Asare A, Matthews JB, Berry S, Sanil A, Schwab R, Symmans WF, van 't Veer L, Yee D, DeMichele A, Hylton NM, Melisko M, Perlmutter J, Rugo HS, Berry DA, Esserman LJ. PMID: 32053137.
      View in: PubMed   Mentions: 13     Fields:    
    20. Abdominal Imaging of Pancreatic Cysts and Cyst-Associated Pancreatic Cancer in BRCA1/2 Mutation Carriers: A Retrospective Cross-Sectional Study. J Am Coll Surg. 2020 01; 230(1):53-63.e1. Cao CX, Sharib JM, Blanco AM, Goldberg D, Bracci P, Mukhtar RA, Esserman LJ, Kirkwood KS. PMID: 31672679.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast. NPJ Breast Cancer. 2019; 5:29. Piper ML, Wong J, Fahrner-Scott K, Ewing C, Alvarado M, Esserman LJ, Mukhtar RA. PMID: 31508489.
      View in: PubMed   Mentions:
    22. Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer. JAMA Oncol. 2019 Aug 08. Yu NY, Iftimi A, Yau C, Tobin NP, van 't Veer L, Hoadley KA, Benz CC, Nordenskjöld B, Fornander T, Stål O, Czene K, Esserman LJ, Lindström LS. PMID: 31393518.
      View in: PubMed   Mentions: 1     Fields:    
    23. A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel. NPJ Breast Cancer. 2019; 5:17. Piawah S, Hyland C, Umetsu SE, Esserman LJ, Rugo HS, Chien AJ. PMID: 31240240.
      View in: PubMed   Mentions:
    24. Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer. Clin Cancer Res. 2019 09 01; 25(17):5388-5397. Magbanua MJM, Yau C, Wolf DM, Lee JS, Chattopadhyay A, Scott JH, Bowlby-Yoder E, Hwang ES, Alvarado M, Ewing CA, Delson AL, Van't Veer LJ, Esserman L, Park JW. PMID: 31142502.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    25. Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy. Clin Breast Cancer. 2019 12; 19(6):443-449.e1. Dreher N, Hadeler EK, Hartman SJ, Wong EC, Acerbi I, Rugo HS, Majure MC, Chien AJ, Esserman LJ, Melisko ME. PMID: 31285177.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL. J Magn Reson Imaging. 2019 12; 50(6):1742-1753. Li W, Newitt DC, Wilmes LJ, Jones EF, Arasu V, Gibbs J, La Yun B, Li E, Partridge SC, Kornak J, Esserman LJ, Hylton NM. PMID: 31026118.
      View in: PubMed   Mentions: 2     Fields:    
    27. Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol. NPJ Breast Cancer. 2019; 5:12. Jones EF, Ray KM, Li W, Chien AJ, Mukhtar RA, Esserman LJ, Franc BL, Seo Y, Pampaloni MH, Joe BN, Hylton NM. PMID: 31016232.
      View in: PubMed   Mentions:
    28. A response to "Personalised medicine and population health: breast and ovarian cancer". Hum Genet. 2019 Mar; 138(3):287-289. Antoniou A, Anton-Culver H, Borowsky A, Broeders M, Brooks J, Chiarelli A, Chiquette J, Cuzick J, Delaloge S, Devilee P, Dorval M, Easton D, Eisen A, Eklund M, Eloy L, Esserman L, Garcia-Closas M, Goldgar D, Hall P, Knoppers BM, Kraft P, La Croix A, Madalensky L, Mavaddat N, Mittman N, Nabi H, Olopade O, Pashayan N, Schmidt M, Shieh Y, Simard J, Stover-Fiscallini A, Tice JA, Van't Veer L, Wenger N, Wolfson M, Yau C, Ziv E. PMID: 30810870.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    29. MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial. J Clin Oncol. 2020 Apr 01; 38(10):1059-1069. Chien AJ, Tripathy D, Albain KS, Symmans WF, Rugo HS, Melisko ME, Wallace AM, Schwab R, Helsten T, Forero-Torres A, Stringer-Reasor E, Ellis ED, Kaplan HG, Nanda R, Jaskowiak N, Murthy R, Godellas C, Boughey JC, Elias AD, Haley BB, Kemmer K, Isaacs C, Clark AS, Lang JE, Lu J, Korde L, Edmiston KK, Northfelt DW, Viscusi RK, Yee D, Perlmutter J, Hylton NM, Van't Veer LJ, DeMichele A, Wilson A, Peterson G, Buxton MB, Paoloni M, Clennell J, Berry S, Matthews JB, Steeg K, Singhrao R, Hirst GL, Sanil A, Yau C, Asare SM, Berry DA, Esserman LJ. PMID: 32031889.
      View in: PubMed   Mentions: 3     Fields:    
    30. Should we rename low risk cancers? BMJ. 2019 Jan 23; 364:k4699. Esserman LJ, Varma M. PMID: 30674473.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    31. Evaluation of National Comprehensive Cancer Network guideline-based Tool for Risk Assessment for breast and ovarian Cancer (N-TRAC): A patient-reported survey for genetic high-risk assessment for breast and ovarian cancers in women. J Genet Couns. 2019 06; 28(3):507-515. Ozanne EM, Howe R, Mallinson D, Esserman L, Van't Veer LJ, Kaplan CP. PMID: 30663827.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches. JNCI Cancer Spectr. 2018 Oct; 2(4):pky067. Eklund M, Broglio K, Yau C, Connor JT, Stover Fiscalini A, Esserman LJ. PMID: 31360882.
      View in: PubMed   Mentions:
    33. Erratum: Author Correction: Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2019; 5:2. Boughey JC, Alvarado MD, Lancaster RB, Symmans WF, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Goodellas C, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ. PMID: 30675512.
      View in: PubMed   Mentions:
    34. Functional Status and Survival After Breast Cancer Surgery in Nursing Home Residents. JAMA Surg. 2018 12 01; 153(12):1090-1096. Tang V, Zhao S, Boscardin J, Sudore R, Covinsky K, Walter LC, Esserman L, Mukhtar R, Finlayson E. PMID: 30167636.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    35. Precision risk-based screening might maximize benefit and minimize harm. Nat Rev Clin Oncol. 2018 11; 15(11):661-662. Esserman LJ, LaCroix AZ. PMID: 30218030.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    36. Test-retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial. J Magn Reson Imaging. 2019 06; 49(6):1617-1628. Newitt DC, Zhang Z, Gibbs JE, Partridge SC, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Aliu S, Li W, Cimino L, Joe BN, Umphrey H, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis J, Esserman LJ, Hylton NM. PMID: 30350329.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    37. Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer. NPJ Breast Cancer. 2018; 4:31. Magbanua MJM, Rugo HS, Hauranieh L, Roy R, Scott JH, Lee JC, Hsiao F, Sosa EV, Van't Veer L, Esserman LJ, Park JW. PMID: 30211312.
      View in: PubMed   Mentions:
    38. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology. 2018 12; 289(3):618-627. Partridge SC, Zhang Z, Newitt DC, Gibbs JE, Chenevert TL, Rosen MA, Bolan PJ, Marques HS, Romanoff J, Cimino L, Joe BN, Umphrey HR, Ojeda-Fournier H, Dogan B, Oh K, Abe H, Drukteinis JS, Esserman LJ, Hylton NM. PMID: 30179110.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    39. Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint. NPJ Breast Cancer. 2018; 4:26. Boughey JC, Alvarado MD, Lancaster RB, Fraser Symmans W, Mukhtar R, Wong JM, Ewing CA, Potter DA, Tuttle TM, Hieken TJ, Carter JM, Jakub JW, Kaplan HG, Buchanan CL, Jaskowiak NT, Sattar HA, Mueller J, Nanda R, Isaacs CJ, Pohlmann PR, Lynce F, Tousimis EA, Zeck JC, Lee MC, Lang JE, Mhawech-Fauceglia P, Rao R, Taback B, Chen M, Kalinsky KM, Hibshoosh H, Killelea B, Sanft T, Hirst GL, Asare S, Matthews JB, Perlmutter J, Esserman LJ. PMID: 30131975.
      View in: PubMed   Mentions:
    40. Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis. NPJ Breast Cancer. 2018; 4:24. Huang SY, Franc BL, Harnish RJ, Liu G, Mitra D, Copeland TP, Arasu VA, Kornak J, Jones EF, Behr SC, Hylton NM, Price ER, Esserman L, Seo Y. PMID: 30131973.
      View in: PubMed   Mentions:
    41. Evaluation of the HER/PI3K/AKT Family Signaling Network as a Predictive Biomarker of Pathologic Complete Response for Patients With Breast Cancer Treated With Neratinib in the I-SPY 2 TRIAL. JCO Precis Oncol. 2018; 2. Wulfkuhle JD, Yau C, Wolf DM, Vis DJ, Gallagher RI, Brown-Swigart L, Hirst G, Voest EE, DeMichele A, Hylton N, Symmans F, Yee D, Esserman L, Berry D, Liu M, Park JW, Wessels LFA, Van't Veer L, Petricoin EF. PMID: 32914002.
      View in: PubMed   Mentions:
    42. Breast Conservation and Negative Margins in Invasive Lobular Carcinoma: The Impact of Oncoplastic Surgery and Shave Margins in 358 Patients. Ann Surg Oncol. 2018 Oct; 25(11):3165-3170. Mukhtar RA, Wong J, Piper M, Zhu Z, Fahrner-Scott K, Mamounas M, Sbitany H, Alvarado M, Foster R, Ewing C, Esserman L. PMID: 30054826.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    43. The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia. Future Oncol. 2018 Oct; 14(24):2461-2469. Mustoe MM, Lee CM, Melisko ME, Esserman LJ, Rugo HS. PMID: 30001151.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    44. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J Natl Cancer Inst. 2018 07 01; 110(7):726-733. Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ. PMID: 29361175.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    45. Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis. J Natl Cancer Inst. 2018 06 01; 110(6):560-567. Bidard FC, Michiels S, Riethdorf S, Mueller V, Esserman LJ, Lucci A, Naume B, Horiguchi J, Gisbert-Criado R, Sleijfer S, Toi M, Garcia-Saenz JA, Hartkopf A, Generali D, Rothé F, Smerage J, Muinelo-Romay L, Stebbing J, Viens P, Magbanua MJM, Hall CS, Engebraaten O, Takata D, Vidal-Martínez J, Onstenk W, Fujisawa N, Diaz-Rubio E, Taran FA, Cappelletti MR, Ignatiadis M, Proudhon C, Wolf DM, Bauldry JB, Borgen E, Nagaoka R, Carañana V, Kraan J, Maestro M, Brucker SY, Weber K, Reyal F, Amara D, Karhade MG, Mathiesen RR, Tokiniwa H, Llombart-Cussac A, Meddis A, Blanche P, d'Hollander K, Cottu P, Park JW, Loibl S, Latouche A, Pierga JY, Pantel K. PMID: 29659933.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    46. Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers. BJS Open. 2018 Aug; 2(4):162-174. Winters ZE, Horsnell J, Elvers KT, Maxwell AJ, Jones LJ, Shaaban AM, Schmid P, Williams NR, Beswick A, Greenwood R, Ingram JC, Saunders C, Vaidya JS, Esserman L, Jatoi I, Brunt AM. PMID: 30079385.
      View in: PubMed   Mentions:
    47. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. AJR Am J Roentgenol. 2018 Jun; 210(6):1376-1385. Scheel JR, Kim E, Partridge SC, Lehman CD, Rosen MA, Bernreuter WK, Pisano ED, Marques HS, Morris EA, Weatherall PT, Polin SM, Newstead GM, Esserman LJ, Schnall MD, Hylton NM. PMID: 29708782.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    48. Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy. BMC Anesthesiol. 2018 04 16; 18(1):41. Chiu C, Aleshi P, Esserman LJ, Inglis-Arkell C, Yap E, Whitlock EL, Harbell MW. PMID: 29661153.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Initial Clinical Experience With an Inducible Magnetic Seed System for Preoperative Breast Lesion Localization. AJR Am J Roentgenol. 2018 Apr; 210(4):913-917. Price ER, Khoury AL, Esserman LJ, Joe BN, Alvarado MD. PMID: 29446680.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. Complications After Total Skin-Sparing Mastectomy and Expander-Implant Reconstruction: Effects of Radiation Therapy on the Stages of Reconstruction. Ann Plast Surg. 2018 Jan; 80(1):10-13. Peled AW, Sears M, Wang F, Foster RD, Alvarado M, Wong J, Ewing CA, Sbitany H, Esserman LJ, Fowble B. PMID: 28671888.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIAL. J Med Imaging (Bellingham). 2018 01; 5(1):011014. Olshen A, Wolf D, Jones EF, Newitt D, van ‘t Veer LJ, Yau C, Esserman L, Wulfkuhle JD, Gallagher RI, Singer L, Petricoin EF, Hylton N, Park CC. PMID: 29296631.
      View in: PubMed   Mentions:
    52. Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels. Oncotarget. 2018 Jan 30; 9(8):7832-7843. Kwong A, Ho JCW, Shin VY, Kurian AW, Tai E, Esserman LJ, Weitzel JN, Lin PH, Field M, Domchek SM, Lo J, Ngan HYS, Ma ESK, Chan TL, Ford JM. PMID: 29487695.
      View in: PubMed   Mentions: 1     Fields:    
    53. Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer. N Engl J Med. 2017 12 07; 377(23):2287-2289. DeMichele A, Yee D, Esserman L. PMID: 29211674.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimals
    54. Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades. JAMA Oncol. 2017 Nov 01; 3(11):1503-1510. Esserman LJ, Yau C, Thompson CK, van 't Veer LJ, Borowsky AD, Hoadley KA, Tobin NP, Nordenskjöld B, Fornander T, Stål O, Benz CC, Lindström LS. PMID: 28662222.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    55. The value of embedding: integrated palliative care for patients with metastatic breast cancer. Breast Cancer Res Treat. 2018 02; 167(3):703-708. Rabow M, Small R, Jow A, Majure M, Chien A, Melisko M, Belkora J, Esserman LJ, Rugo H. PMID: 29086230.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    56. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2018 01; 167(1):117-122. Rice BA, Ver Hoeve ES, DeLuca AN, Esserman LJ, Rugo HS, Melisko ME. PMID: 28921303.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCTClinical Trials
    57. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017; 3:34. Esserman LJ. PMID: 28944288.
      View in: PubMed   Mentions:
    58. Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors. Breast Cancer Res. 2017 Sep 11; 19(1):107. Bartelink IH, Prideaux B, Krings G, Wilmes L, Lee PRE, Bo P, Hann B, Coppé JP, Heditsian D, Swigart-Brown L, Jones EF, Magnitsky S, Keizer RJ, de Vries N, Rosing H, Pawlowska N, Thomas S, Dhawan M, Aggarwal R, Munster PN, Esserman LJ, Ruan W, Wu AHB, Yee D, Dartois V, Savic RM, Wolf DM, van 't Veer L. PMID: 28893315.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    59. DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial. NPJ Breast Cancer. 2017; 3:31. Wolf DM, Yau C, Sanil A, Glas A, Petricoin E, Wulfkuhle J, Severson TM, Linn S, Brown-Swigart L, Hirst G, Buxton M, DeMichele A, Hylton N, Symmans F, Yee D, Paoloni M, Esserman L, Berry D, Rugo H, Olopade O, van 't Veer L. PMID: 28948212.
      View in: PubMed   Mentions:
    60. Tamoxifen therapy benefit for patients with 70-gene signature high and low risk. Breast Cancer Res Treat. 2017 Nov; 166(2):593-601. van 't Veer LJ, Yau C, Yu NY, Benz CC, Nordenskjöld B, Fornander T, Stål O, Esserman LJ, Lindström LS. PMID: 28776283.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Erratum to: Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy. Breast Cancer Res Treat. 2017 08; 165(1):161. Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP. PMID: 28660429.
      View in: PubMed   Mentions: 1     Fields:    
    62. Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women. Clin Breast Cancer. 2018 02; 18(1):e107-e113. Fowble B, Jairam AK, Wang F, Peled A, Alvarado M, Ewing C, Esserman L, Park C, Lazar A. PMID: 28830795.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    63. Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat. 2017 Aug; 165(1):129-138. Vidula N, Yau C, Li J, Esserman LJ, Rugo HS. PMID: 28577080.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    64. Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat. 2017 Aug; 165(1):181-191. Campbell JI, Yau C, Krass P, Moore D, Carey LA, Au A, Chhieng D, Giri D, Livasy C, Mies C, Rabban J, Sarode VR, Singh B, Esserman L, Chen YY. PMID: 28577078.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    65. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy. Breast Cancer Res Treat. 2017 Aug; 165(1):151-159. Chien AJ, Chambers J, Mcauley F, Kaplan T, Letourneau J, Hwang J, Kim MO, Melisko ME, Rugo HS, Esserman LJ, Rosen MP. PMID: 28503722.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    66. Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial. JAMA Oncol. 2017 Mar 01; 3(3):313-319. Melisko ME, Goldman ME, Hwang J, De Luca A, Fang S, Esserman LJ, Chien AJ, Park JW, Rugo HS. PMID: 27832260.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    67. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. JAMA. 2017 02 14; 317(6):606-614. Rugo HS, Klein P, Melin SA, Hurvitz SA, Melisko ME, Moore A, Park G, Mitchel J, Bågeman E, D'Agostino RB, Ver Hoeve ES, Esserman L, Cigler T. PMID: 28196257.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    68. Precision surgery and avoiding over-treatment. Eur J Surg Oncol. 2017 May; 43(5):938-943. Hosseini A, Khoury AL, Esserman LJ. PMID: 28238520.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. J Natl Cancer Inst. 2017 01; 109(5). Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA. PMID: 28130475.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    70. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol. 2017 Apr 01; 35(10):1061-1069. Ellis MJ, Suman VJ, Hoog J, Goncalves R, Sanati S, Creighton CJ, DeSchryver K, Crouch E, Brink A, Watson M, Luo J, Tao Y, Barnes M, Dowsett M, Budd GT, Winer E, Silverman P, Esserman L, Carey L, Ma CX, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther JM, Dayao Z, Ota D, Leitch M, Olson JA, Allred DC, Hunt K. PMID: 28045625.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCellsCTClinical Trials
    71. Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer. Clin Breast Cancer. 2017 06; 17(3):e155-e159. Jones EF, Ray KM, Li W, Seo Y, Franc BL, Chien AJ, Esserman LJ, Pampaloni MH, Joe BN, Hylton NM. PMID: 28110902.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    72. MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial. J Magn Reson Imaging. 2017 07; 46(1):290-302. Bolan PJ, Kim E, Herman BA, Newstead GM, Rosen MA, Schnall MD, Pisano ED, Weatherall PT, Morris EA, Lehman CD, Garwood M, Nelson MT, Yee D, Polin SM, Esserman LJ, Gatsonis CA, Metzger GJ, Newitt DC, Partridge SC, Hylton NM. PMID: 27981651.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    73. Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL. Tomography. 2016 Dec; 2(4):378-387. Li W, Arasu V, Newitt DC, Jones EF, Wilmes L, Gibbs J, Kornak J, Joe BN, Esserman LJ, Hylton NM. PMID: 28066808.
      View in: PubMed   Mentions: 5     Fields:    
    74. Do Prolonged Prophylactic Antibiotics Reduce the Incidence of Surgical-Site Infections in Immediate Prosthetic Breast Reconstruction? Plast Reconstr Surg. 2016 Dec; 138(6):1141-1149. Wang F, Chin R, Piper M, Esserman L, Sbitany H. PMID: 27537226.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer. Breast Cancer Res Treat. 2017 01; 161(1):41-50. Amara D, Wolf DM, van 't Veer L, Esserman L, Campbell M, Yau C. PMID: 27815749.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    76. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2017 01; 161(1):17-28. Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L. PMID: 27785654.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    77. Adaptive Randomization of Neratinib in Early Breast Cancer. N Engl J Med. 2016 10 20; 375(16):1592-3. Berry D, Esserman L. PMID: 27797314.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. PIPELINEs: Creating Comparable Clinical Knowledge Efficiently by Linking Trial Platforms. Clin Pharmacol Ther. 2016 12; 100(6):713-729. Trusheim MR, Shrier AA, Antonijevic Z, Beckman RA, Campbell RK, Chen C, Flaherty KT, Loewy J, Lacombe D, Madhavan S, Selker HP, Esserman LJ. PMID: 27643536.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    79. The I-SPY approach to drug development. Clin Adv Hematol Oncol. 2016 Oct; 14(10):782-784. Esserman L. PMID: 27930629.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    80. Laura Esserman and Ian Thompson Discuss Strategies for Screening and Treatment of Early-Stage Cancers, and How Clinicians Can Learn From Each Other's Experiences. Oncology (Williston Park). 2016 09 15; 30(9):770, 785-6. Esserman LJ, Thompson IM. PMID: 27633408.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    81. The Novel Application of Genomic Profiling Assays to Shorten Inactive Status for Potential Kidney Transplant Recipients With Breast Cancer. Am J Transplant. 2017 01; 17(1):292-295. Mukhtar RA, Piper ML, Freise C, Van't Veer LJ, Baehner FL, Esserman LJ. PMID: 27501470.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    82. Adaptive Randomization of Neratinib in Early Breast Cancer. N Engl J Med. 2016 Jul 07; 375(1):11-22. Park JW, Liu MC, Yee D, Yau C, van 't Veer LJ, Symmans WF, Paoloni M, Perlmutter J, Hylton NM, Hogarth M, DeMichele A, Buxton MB, Chien AJ, Wallace AM, Boughey JC, Haddad TC, Chui SY, Kemmer KA, Kaplan HG, Isaacs C, Nanda R, Tripathy D, Albain KS, Edmiston KK, Elias AD, Northfelt DW, Pusztai L, Moulder SL, Lang JE, Viscusi RK, Euhus DM, Haley BB, Khan QJ, Wood WC, Melisko M, Schwab R, Helsten T, Lyandres J, Davis SE, Hirst GL, Sanil A, Esserman LJ, Berry DA. PMID: 27406346.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    83. Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer. N Engl J Med. 2016 Jul 07; 375(1):23-34. Rugo HS, Olopade OI, DeMichele A, Yau C, van 't Veer LJ, Buxton MB, Hogarth M, Hylton NM, Paoloni M, Perlmutter J, Symmans WF, Yee D, Chien AJ, Wallace AM, Kaplan HG, Boughey JC, Haddad TC, Albain KS, Liu MC, Isaacs C, Khan QJ, Lang JE, Viscusi RK, Pusztai L, Moulder SL, Chui SY, Kemmer KA, Elias AD, Edmiston KK, Euhus DM, Haley BB, Nanda R, Northfelt DW, Tripathy D, Wood WC, Ewing C, Schwab R, Lyandres J, Davis SE, Hirst GL, Sanil A, Berry DA, Esserman LJ. PMID: 27406347.
      View in: PubMed   Mentions: 96     Fields:    Translation:HumansCTClinical Trials
    84. When Less Is Better, but Physicians Are Afraid Not to Intervene. JAMA Intern Med. 2016 07 01; 176(7):888-9. Esserman L. PMID: 27243587.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    85. Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers. Proteomics Clin Appl. 2016 07; 10(7):720-31. Katchman BA, Barderas R, Alam R, Chowell D, Field MS, Esserman LJ, Wallstrom G, LaBaer J, Cramer DW, Hollingsworth MA, Anderson KS. PMID: 27121307.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    86. Outcomes Following Oncoplastic Reduction Mammoplasty: A Systematic Review. Ann Plast Surg. 2016 May; 76 Suppl 3:S222-6. Piper ML, Esserman LJ, Sbitany H, Peled AW. PMID: 26808743.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    87. Population-based screening for cancer: hope and hype. Nat Rev Clin Oncol. 2016 09; 13(9):550-65. Shieh Y, Eklund M, Sawaya GF, Black WC, Kramer BS, Esserman LJ. PMID: 27071351.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansPHPublic Health
    88. When the Gold Standard Loses Its Luster, Perhaps It Is Time to Change Nomenclature. Ann Intern Med. 2016 05 17; 164(10):694-5. Borowsky A, Esserman L. PMID: 26999728.
      View in: PubMed   Mentions:    Fields:    
    89. Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-Reply. JAMA Oncol. 2016 Mar; 2(3):395-6. Esserman L, Yau C. PMID: 26967177.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    90. Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes. PLoS One. 2016; 11(2):e0142047. Lo WC, Li W, Jones EF, Newitt DC, Kornak J, Wilmes LJ, Esserman LJ, Hylton NM. PMID: 26886725.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    91. A phase 1b study of the Akt-inhibitor MK-2206 in combination with weekly paclitaxel and trastuzumab in patients with advanced HER2-amplified solid tumor malignancies. Breast Cancer Res Treat. 2016 Feb; 155(3):521-30. Chien AJ, Cockerill A, Fancourt C, Schmidt E, Moasser MM, Rugo HS, Melisko ME, Ko AH, Kelley RK, Korn WM, Esserman LJ, van't Veer L, Yau C, Wolf DM, Munster PN. PMID: 26875185.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    92. Time for a randomised clinical trial evaluating breast conserving surgery compared to mastectomy in ipsilateral mutlifocal breast cancer (MFBC)? Breast. 2016 Apr; 26:149-50. Winters ZE, Horsnell J, Schmid P, Jones JL, Shaaban A, Maxwell AJ, Williams N, Esserman L, Jatoi I, Brunt AM. PMID: 26851965.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    93. Detection of ductal carcinoma in situ and subsequent interval cancers. BMJ. 2016 Feb 01; 352:i551. Shieh Y, Eklund M, Esserman L. PMID: 26834245.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    94. CLINICAL DECISIONS. Ductal Carcinoma In Situ. N Engl J Med. 2016 Jan 28; 374(4):390-2. Merrill AL, Esserman L, Morrow M. PMID: 26816018.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    95. The Impact of Radiation Therapy, Lymph Node Dissection, and Hormonal Therapy on Outcomes of Tissue Expander-Implant Exchange in Prosthetic Breast Reconstruction. Plast Reconstr Surg. 2016 Jan; 137(1):1-9. Wang F, Peled AW, Chin R, Fowble B, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H. PMID: 26368331.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    96. Less Is More: The Evolving Surgical Approach to Breast Cancer. Am Soc Clin Oncol Educ Book. 2016; 35:e5-e10. Esserman L, Gallant E, Alvarado M. PMID: 27249759.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    97. Tissue Expander Reconstruction After Total Skin-Sparing Mastectomy: Defining the Effects of Coverage Technique on Nipple/Areola Preservation. Ann Plast Surg. 2016 Jan; 77(1):17-24. Sbitany H, Wang F, Peled AW, Alvarado M, Ewing CA, Esserman LJ, Foster RD. PMID: 25057918.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    98. Neoadjuvant as Future for Drug Development in Breast Cancer--Response. Clin Cancer Res. 2016 Jan 01; 22(1):269. DeMichele A, Yee D, Paoloni M, Berry D, Esserman LJ. PMID: 26728411.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    99. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome. Ann Surg Oncol. 2016 Mar; 23(3):715-21. Johnson J, Esserman L, Ewing C, Alvarado M, Park C, Fowble B. PMID: 26714943.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    100. Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology. 2016 Apr; 279(1):44-55. Hylton NM, Gatsonis CA, Rosen MA, Lehman CD, Newitt DC, Partridge SC, Bernreuter WK, Pisano ED, Morris EA, Weatherall PT, Polin SM, Newstead GM, Marques HS, Esserman LJ, Schnall MD. PMID: 26624971.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    101. Rethinking the Standard for Ductal Carcinoma In Situ Treatment. JAMA Oncol. 2015 Oct; 1(7):881-3. Esserman L, Yau C. PMID: 26291410.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    102. Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer. Ann Surg Oncol. 2015 Oct; 22(10):3338-45. Wang F, Amara D, Peled AW, Sbitany H, Foster RD, Ewing CA, Alvarado M, Esserman LJ. PMID: 26215194.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    103. Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer. Breast Cancer Res Treat. 2015 Aug; 153(1):173-81. Chien AJ, Duralde E, Hwang R, Tsung K, Kao CN, Rugo HS, Melisko ME, Esserman LJ, Munster PN, Cedars M, Kerlikowske K, McCulloch CE, Rosen MP. PMID: 26208485.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    104. Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group. Mod Pathol. 2015 Sep; 28(9):1185-201. Provenzano E, Bossuyt V, Viale G, Cameron D, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Boughey J, Curigliano G, Dixon JM, Esserman L, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Symmans WF. PMID: 26205180.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    105. How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World J Clin Cases. 2015 Jul 16; 3(7):607-13. Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ. PMID: 26244152.
      View in: PubMed   Mentions:
    106. In Regard to Hepel and Wazer. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):953-954. Vaidya JS, Bulsara M, Wenz F, Joseph D, Saunders C, Massarut S, Flyger H, Eiermann W, Alvarado M, Esserman L, Falzon M, Brew-Graves C, Potyka I, Tobias JS, Baum M. PMID: 26194663.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    107. Expanding the Indications for Total Skin-Sparing Mastectomy: Is It Safe for Patients with Locally Advanced Disease? Ann Surg Oncol. 2016 Jan; 23(1):87-91. Peled AW, Wang F, Foster RD, Alvarado M, Ewing CA, Sbitany H, Esserman LJ. PMID: 26170194.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    108. Preventing Overdiagnosis and Overtreatment: Just the Next Step in the Evolution of Breast Cancer Care. J Natl Compr Canc Netw. 2015 Jun; 13(6):737-43. Mukhtar RA, Wong JM, Esserman LJ. PMID: 26085389.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    109. Tumor Involvement of the Nipple in Total Skin-Sparing Mastectomy: Strategies for Management. Ann Surg Oncol. 2015 Nov; 22(12):3803-8. Amara D, Peled AW, Wang F, Ewing CA, Alvarado M, Esserman LJ. PMID: 26023040.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    110. Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response. Breast Cancer Res. 2015 May 29; 17:73. Magbanua MJ, Wolf DM, Yau C, Davis SE, Crothers J, Au A, Haqq CM, Livasy C, Rugo HS, Esserman L, Park JW, van 't Veer LJ. PMID: 26021444.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    111. Coaching patients in the use of decision and communication aids: RE-AIM evaluation of a patient support program. BMC Health Serv Res. 2015 May 28; 15:209. Belkora J, Volz S, Loth M, Teng A, Zarin-Pass M, Moore D, Esserman L. PMID: 26017564.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    112. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol. 2015 Jul; 26(7):1280-91. Bossuyt V, Provenzano E, Symmans WF, Boughey JC, Coles C, Curigliano G, Dixon JM, Esserman LJ, Fastner G, Kuehn T, Peintinger F, von Minckwitz G, White J, Yang W, Badve S, Denkert C, MacGrogan G, Penault-Llorca F, Viale G, Cameron D. PMID: 26019189.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    113. Comparison of Mammographic Findings Following Oncoplastic Mammoplasty and Lumpectomy Without Reconstruction. Ann Surg Oncol. 2016 Jan; 23(1):65-71. Piper M, Peled AW, Sbitany H, Foster RD, Esserman LJ, Price ER. PMID: 25994209.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    114. Approaches to microvascular breast reconstruction after total skin-sparing mastectomy: a comparison of techniques. Ann Plast Surg. 2015 May; 74 Suppl 1:S46-51. Raghavan S, Peled AW, Hansen SL, Esserman LJ, Sbitany H. PMID: 25875911.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    115. Rates of Reconstruction Failure in Patients Undergoing Immediate Reconstruction With Tissue Expanders and/or Implants and Postmastectomy Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):634-41. Fowble B, Park C, Wang F, Peled A, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H, Hanlon A. PMID: 25936815.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    116. Pride, Prejudice, or Science: Attitudes Towards the Results of the TARGIT-A Trial of Targeted Intraoperative Radiation Therapy for Breast Cancer. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):491-7. Vaidya JS, Bulsara M, Wenz F, Joseph D, Saunders C, Massarut S, Flyger H, Eiermann W, Alvarado M, Esserman L, Falzon M, Brew-Graves C, Potyka I, Tobias JS, Baum M. PMID: 26068479.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    117. The impact of breast mass on outcomes of total skin-sparing mastectomy and immediate tissue expander-based breast reconstruction. Plast Reconstr Surg. 2015 Mar; 135(3):672-9. Wang F, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H. PMID: 25719689.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    118. The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer. Clin Cancer Res. 2015 Jul 01; 21(13):2911-5. DeMichele A, Yee D, Berry DA, Albain KS, Benz CC, Boughey J, Buxton M, Chia SK, Chien AJ, Chui SY, Clark A, Edmiston K, Elias AD, Forero-Torres A, Haddad TC, Haley B, Haluska P, Hylton NM, Isaacs C, Kaplan H, Korde L, Leyland-Jones B, Liu MC, Melisko M, Minton SE, Moulder SL, Nanda R, Olopade OI, Paoloni M, Park JW, Parker BA, Perlmutter J, Petricoin EF, Rugo H, Symmans F, Tripathy D, van't Veer LJ, Viscusi RK, Wallace A, Wolf D, Yau C, Esserman LJ. PMID: 25712686.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    119. Development, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization. J Am Med Inform Assoc. 2015 May; 22(3):577-86. Warner JL, Maddux SE, Hughes KS, Krauss JC, Yu PP, Shulman LN, Mayer DK, Hogarth M, Shafarman M, Stover Fiscalini A, Esserman L, Alschuler L, Koromia GA, Gonzaga Z, Ambinder EP. PMID: 25604811.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    120. Preoperative Breast Pain Predicts Persistent Breast Pain and Disability After Breast Cancer Surgery. J Pain Symptom Manage. 2015 Jun; 49(6):981-94. Langford DJ, Schmidt B, Levine JD, Abrams G, Elboim C, Esserman L, Hamolsky D, Mastick J, Paul SM, Cooper B, Kober K, Dodd M, Dunn L, Aouizerat B, Miaskowski C. PMID: 25527442.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    121. Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease. Cancer Epidemiol Biomarkers Prev. 2015 Feb; 24(2):435-41. Marks JR, Anderson KS, Engstrom P, Godwin AK, Esserman LJ, Longton G, Iversen ES, Mathew A, Patriotis C, Pepe MS. PMID: 25471344.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    122. SIS.NET: a randomized controlled trial evaluating a web-based system for symptom management after treatment of breast cancer. Cancer. 2015 Mar 15; 121(6):893-9. Wheelock AE, Bock MA, Martin EL, Hwang J, Ernest ML, Rugo HS, Esserman LJ, Melisko ME. PMID: 25469673.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    123. Expression profiling of circulating tumor cells in metastatic breast cancer. Breast Cancer Res Treat. 2015 Jan; 149(1):121-31. Lang JE, Scott JH, Wolf DM, Novak P, Punj V, Magbanua MJ, Zhu W, Mineyev N, Haqq CM, Crothers JR, Esserman LJ, Tripathy D, van 't Veer L, Park JW. PMID: 25432738.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    124. Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes. Plast Reconstr Surg. 2014 Sep; 134(3):396-404. Sbitany H, Wang F, Peled AW, Lentz R, Alvarado M, Ewing CA, Esserman LJ, Fowble B, Foster RD. PMID: 25158699.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    125. Aggregate cost of mammography screening in the United States. Ann Intern Med. 2014 Aug 19; 161(4):305. Eklund M, O'Donoghue C, Esserman LJ. PMID: 25133367.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    126. Randomized trial of drain antisepsis after mastectomy and immediate prosthetic breast reconstruction. Ann Surg Oncol. 2014 Oct; 21(10):3240-8. Degnim AC, Hoskin TL, Brahmbhatt RD, Warren-Peled A, Loprinzi M, Pavey ES, Boughey JC, Hieken TJ, Jacobson S, Lemaine V, Jakub JW, Irwin C, Foster RD, Sbitany H, Saint-Cyr M, Duralde E, Ramaker S, Chin R, Sieg M, Wildeman M, Scow JS, Patel R, Ballman K, Baddour LM, Esserman LJ. PMID: 25096386.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    127. Haste makes waste, but lack of urgency is opportunity lost. Breast Cancer Res Treat. 2014 Aug; 147(1):223-4. Esserman L, Hayes M, Alvarado M. PMID: 25062705.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    128. Impact of total skin-sparing mastectomy incision type on reconstructive complications following radiation therapy. Plast Reconstr Surg. 2014 Aug; 134(2):169-75. Peled AW, Foster RD, Ligh C, Esserman LJ, Fowble B, Sbitany H. PMID: 24732652.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    129. Moving beyond the breast cancer screening debate. J Womens Health (Larchmt). 2014 Aug; 23(8):629-30. Esserman L, O'Kane ME. PMID: 25068713.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    130. Total skin-sparing mastectomy and immediate breast reconstruction: an evolution of technique and assessment of outcomes. Ann Surg Oncol. 2014 Oct; 21(10):3223-30. Wang F, Peled AW, Garwood E, Fiscalini AS, Sbitany H, Foster RD, Alvarado M, Ewing C, Hwang ES, Esserman LJ. PMID: 25052246.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    131. Immediate implant-based breast reconstruction following total skin-sparing mastectomy in women with a history of augmentation mammaplasty: assessing the safety profile. Plast Reconstr Surg. 2014 Jul; 134(1):1-9. Sbitany H, Wang F, Saeed L, Alvarado M, Ewing CA, Esserman LJ, Foster RD. PMID: 24622575.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    132. Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014 Aug; 23(8):1464-83. Elias SG, Adams A, Wisner DJ, Esserman LJ, van't Veer LJ, Mali WP, Gilhuijs KG, Hylton NM. PMID: 24807204.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    133. Oncoplastic mammoplasty as a strategy for reducing reconstructive complications associated with postmastectomy radiation therapy. Breast J. 2014 May-Jun; 20(3):302-7. Peled AW, Sbitany H, Foster RD, Esserman LJ. PMID: 24750512.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    134. Fifty years of age-based screening: time for a new risk-based screening approach. Evid Based Med. 2014 Oct; 19(5):183. Kerlikowske K, O'Kane ME, Esserman LJ. PMID: 24785471.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    135. Patient-reported outcomes and satisfaction after total skin-sparing mastectomy and immediate expander-implant reconstruction. Ann Plast Surg. 2014 May; 72 Suppl 1:S48-52. Peled AW, Duralde E, Foster RD, Fiscalini AS, Esserman LJ, Hwang ES, Sbitany H. PMID: 24317238.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    136. Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol. 2014 Sep; 21(9):2889-96. Cureton EL, Yau C, Alvarado MD, Krontiras H, Ollila DW, Ewing CA, Monnier S, Esserman LJ. PMID: 24788555.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    137. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 2014 May; 15(6):e234-42. Esserman LJ, Thompson IM, Reid B, Nelson P, Ransohoff DF, Welch HG, Hwang S, Berry DA, Kinzler KW, Black WC, Bissell M, Parnes H, Srivastava S. PMID: 24807866.
      View in: PubMed   Mentions: 102     Fields:    Translation:Humans
    138. Accelerated approval for pertuzumab in the neoadjuvant setting: winds of change? Clin Cancer Res. 2014 Jul 15; 20(14):3632-6. Esserman LJ, DeMichele A. PMID: 24748554.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    139. Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657). Cancer Med. 2014 Jun; 3(3):693-701. Clark AS, Chen J, Kapoor S, Friedman C, Mies C, Esserman L, DeMichele A. PMID: 24719175.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    140. Setting a research agenda for ductal carcinoma in situ that meets the current need for change. Ann Intern Med. 2014 Apr 01; 160(7):511-2. Esserman L, Alvarado M. PMID: 24566896.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    141. Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time? Breast Cancer Res Treat. 2014 Apr; 144(2):371-8. Esserman LJ, Alvarado MD, Howe RJ, Mohan AJ, Harrison B, Park C, O'Donoghue C, Ozanne EM. PMID: 24584875.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    142. Making better doctors: a survey of premedical interns working as health coaches. J Cancer Educ. 2014 Mar; 29(1):167-74. Zarin-Pass M, Belkora J, Volz S, Esserman L. PMID: 24163016.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    143. Abstract 124: outcomes of total skin-sparing mastectomy and reconstruction in 924 breasts over 11 years. Plast Reconstr Surg. 2014 Mar; 133(3 Suppl):139. Wang F, Peled A, Foster R, Wang E, Ewing C, Alvarado M, Esserman L, Sbitany H. PMID: 25942235.
      View in: PubMed   Mentions:    Fields:    
    144. Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2. Cancer. 2014 May 15; 120(10):1557-64. Jackson SA, Davis AA, Li J, Yi N, McCormick SR, Grant C, Fallen T, Crawford B, Loranger K, Litton J, Arun B, Vande Wydeven K, Sidani A, Farmer K, Sanders M, Hoskins K, Nussbaum R, Esserman L, Garber JE, Kaklamani VG. PMID: 24522996.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    145. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med. 2014 Feb 04; 160(3):145. O'Donoghue C, Eklund M, Ozanne EM, Esserman LJ. PMID: 24658691.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansPHPublic Health
    146. Real-Time Measurement of Functional Tumor Volume by MRI to Assess Treatment Response in Breast Cancer Neoadjuvant Clinical Trials: Validation of the Aegis SER Software Platform. Transl Oncol. 2014 Feb; 7(1):94-100. Newitt DC, Aliu SO, Witcomb N, Sela G, Kornak J, Esserman L, Hylton NM. PMID: 24772212.
      View in: PubMed   Mentions:
    147. Mammographic screening detects low-risk tumor biology breast cancers. Breast Cancer Res Treat. 2014 Feb; 144(1):103-11. Drukker CA, Schmidt MK, Rutgers EJ, Cardoso F, Kerlikowske K, Esserman LJ, van Leeuwen FE, Pijnappel RM, Slaets L, Bogaerts J, Van't Veer LJ. PMID: 24469641.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    148. Development of a personalized decision aid for breast cancer risk reduction and management. BMC Med Inform Decis Mak. 2014 Jan 14; 14:4. Ozanne EM, Howe R, Omer Z, Esserman LJ. PMID: 24422989.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    149. Changing the terminology of cancer--reply. JAMA. 2014 Jan 08; 311(2):203. Esserman LJ, Thompson IM, Reid BJ. PMID: 24399568.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    150. Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy. J Magn Reson Imaging. 2014 Aug; 40(2):476-82. Jafri NF, Newitt DC, Kornak J, Esserman LJ, Joe BN, Hylton NM. PMID: 24347097.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    151. Evolving paradigm for imaging, diagnosis, and management of DCIS. J Am Coll Radiol. 2013 Dec; 10(12):918-23. Wells CJ, O'Donoghue C, Ojeda-Fournier H, Retallack HE, Esserman LJ. PMID: 24295941.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    152. Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Res Treat. 2014 Jan; 143(1):135-40. Alvarado MD, Conolly J, Park C, Sakata T, Mohan AJ, Harrison BL, Hayes M, Esserman LJ, Ozanne EM. PMID: 24292868.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    153. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet. 2014 Feb 15; 383(9917):603-13. Vaidya JS, Wenz F, Bulsara M, Tobias JS, Joseph DJ, Keshtgar M, Flyger HL, Massarut S, Alvarado M, Saunders C, Eiermann W, Metaxas M, Sperk E, Sütterlin M, Brown D, Esserman L, Roncadin M, Thompson A, Dewar JA, Holtveg HM, Pigorsch S, Falzon M, Harris E, Matthews A, Brew-Graves C, Potyka I, Corica T, Williams NR, Baum M. PMID: 24224997.
      View in: PubMed   Mentions: 159     Fields:    Translation:Humans
    154. Screening: biology dictates the fate of young women with breast cancer. Nat Rev Clin Oncol. 2013 Dec; 10(12):673-5. Eklund M, Esserman LJ. PMID: 24189468.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    155. The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. PLoS One. 2013; 8(10):e79114. Campbell MJ, Wolf D, Mukhtar RA, Tandon V, Yau C, Au A, Baehner F, van't Veer L, Berry D, Esserman LJ. PMID: 24205370.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    156. Impact of ductal carcinoma in situ terminology on patient treatment preferences. JAMA Intern Med. 2013 Oct 28; 173(19):1830-1. Omer ZB, Hwang ES, Esserman LJ, Howe R, Ozanne EM. PMID: 23978843.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    157. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013 Aug 28; 310(8):797-8. Esserman LJ, Thompson IM, Reid B. PMID: 23896967.
      View in: PubMed   Mentions: 119     Fields:    Translation:Humans
    158. Total skin-sparing mastectomy in BRCA mutation carriers. Ann Surg Oncol. 2014 Jan; 21(1):37-41. Peled AW, Irwin CS, Hwang ES, Ewing CA, Alvarado M, Esserman LJ. PMID: 23982256.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    159. The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care. Breast Cancer Res Treat. 2013 Jul; 140(2):417-25. Elson SL, Hiatt RA, Anton-Culver H, Howell LP, Naeim A, Parker BA, Van't Veer LJ, Hogarth M, Pierce JP, Duwors RJ, Hajopoulos K, Esserman LJ. PMID: 23887672.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    160. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer. Ann Surg Oncol. 2013 Sep; 20(9):2873-80. Alvarado MD, Mohan AJ, Esserman LJ, Park CC, Harrison BL, Howe RJ, Thorsen C, Ozanne EM. PMID: 23812769.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    161. Clinically meaningful tumor reduction rates vary by prechemotherapy MRI phenotype and tumor subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Ann Surg Oncol. 2013 Nov; 20(12):3823-30. Mukhtar RA, Yau C, Rosen M, Tandon VJ, Hylton N, Esserman LJ. PMID: 23780381.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    162. Feasibility of Performing Total Skin-Sparing Mastectomy in Patients With Prior Circumareolar Mastopexy or Reduction Mammoplasty Incisions. Ann Plast Surg. 2013 Jun 19. Vaughn CJ, Peled AW, Esserman LJ, Foster RD. PMID: 23788153.
      View in: PubMed   Mentions: 3     Fields:    
    163. Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new thresholds for intervention. Breast Cancer Res Treat. 2013 Jun; 139(3):769-77. Flowers CI, O'Donoghue C, Moore D, Goss A, Kim D, Kim JH, Elias SG, Fridland J, Esserman LJ. PMID: 23764994.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    164. Recognising the benefits and harms of breast cancer screening: an opportunity to target improvement. Br J Cancer. 2013 Jun 11; 108(11):2200-1. O'Donoghue C, Esserman L. PMID: 23744278.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    165. Total skin-sparing mastectomy: a systematic review of oncologic outcomes and postoperative complications. Ann Plast Surg. 2013 Apr; 70(4):435-7. Piper M, Peled AW, Foster RD, Moore DH, Esserman LJ. PMID: 23486127.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    166. Developing safety criteria for introducing new agents into neoadjuvant trials. Clin Cancer Res. 2013 Jun 01; 19(11):2817-23. DeMichele A, Berry DA, Zujewski J, Hunsberger S, Rubinstein L, Tomaszewski JE, Kelloff G, Perlmutter J, Buxton M, Lyandres J, Albain KS, Benz C, Chien AJ, Haluska P, Leyland-Jones B, Liu MC, Munster P, Olopade O, Park JW, Parker BA, Pusztai L, Tripathy D, Rugo H, Yee D, Esserman L. PMID: 23470967.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    167. Reply: The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy. Plast Reconstr Surg. 2013 Feb; 131(2):279e. Peled AW, Esserman LJ. PMID: 23358028.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    168. An optimized five-gene multi-platform predictor of hormone receptor negative and triple negative breast cancer metastatic risk. Breast Cancer Res. 2013; 15(5):R103. Yau C, Sninsky J, Kwok S, Wang A, Degnim A, Ingle JN, Gillett C, Tutt A, Waldman F, Moore D, Esserman L, Benz CC. PMID: 24172169.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    169. Physician behaviors surrounding the implementation of decision and communication AIDS in a breast cancer clinic: a qualitative analysis of staff intern perceptions. J Cancer Educ. 2012 Dec; 27(4):764-9. Pass M, Volz S, Teng A, Esserman L, Belkora J. PMID: 22923382.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    170. Will early detection for breast cancer ever work? Clin Chem. 2013 Jan; 59(1):190-3. Esserman L, Ozanne E, van't Veer L. PMID: 23193061.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    171. Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development. J Clin Oncol. 2012 Dec 20; 30(36):4584-6; author reply 4588-9. Yee D, Haddad T, Albain K, Barker A, Benz C, Boughey J, Buxton M, Chien AJ, DeMichele A, Dilts D, Elias A, Haluska P, Hogarth M, Hu A, Hytlon N, Kaplan HG, Kelloff GG, Khan Q, Lang J, Leyland-Jones B, Liu M, Nanda R, Northfelt D, Olopade OI, Park J, Parker B, Parkinson D, Pearson-White S, Perlmutter J, Pusztai L, Symmans F, Rugo H, Tripathy D, Wallace A, Wholley D, Van't Veer L, Berry DA, Esserman L. PMID: 23169510.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    172. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013 Mar 01; 31(7):961-5. Khatcheressian JL, Hurley P, Bantug E, Esserman LJ, Grunfeld E, Halberg F, Hantel A, Henry NL, Muss HB, Smith TJ, Vogel VG, Wolff AC, Somerfield MR, Davidson NE. PMID: 23129741.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansPHPublic Health
    173. Molecular analysis of HER2 signaling in human breast cancer by functional protein pathway activation mapping. Clin Cancer Res. 2012 Dec 01; 18(23):6426-35. Wulfkuhle JD, Berg D, Wolff C, Langer R, Tran K, Illi J, Espina V, Pierobon M, Deng J, DeMichele A, Walch A, Bronger H, Becker I, Waldhör C, Höfler H, Esserman L, Liotta LA, Becker KF, Petricoin EF. PMID: 23045247.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    174. Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(1):35-43. Lips EH, Mukhtar RA, Yau C, de Ronde JJ, Livasy C, Carey LA, Loo CE, Vrancken-Peeters MJ, Sonke GS, Berry DA, Van't Veer LJ, Esserman LJ, Wesseling J, Rodenhuis S, Shelley Hwang E. PMID: 22961065.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    175. Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors. Breast Cancer Res Treat. 2012 Oct; 135(3):913-22. Petrillo LA, Wolf DM, Kapoun AM, Wang NJ, Barczak A, Xiao Y, Korkaya H, Baehner F, Lewicki J, Wicha M, Park JW, Spellman PT, Gray JW, Van't Veer L, Esserman LJ. PMID: 22941572.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimals
    176. Increasing the time to expander-implant exchange after postmastectomy radiation therapy reduces expander-implant failure. Plast Reconstr Surg. 2012 Sep; 130(3):503-9. Peled AW, Foster RD, Esserman LJ, Park CC, Hwang ES, Fowble B. PMID: 22929235.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    177. Breast cancer screening: the questions answered. Nat Rev Clin Oncol. 2012 10; 9(10):599-605. Autier P, Esserman LJ, Flowers CI, Houssami N. PMID: 22889976.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    178. The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors. Breast Cancer Res Treat. 2012 Aug; 134(3):1327-35. Bock M, Moore D, Hwang J, Shumay D, Lawson L, Hamolsky D, Esserman L, Rugo H, Chien AJ, Park J, Munster P, Melisko M. PMID: 22798157.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    179. Adoption, acceptability, and accuracy of an online clinical trial matching website for breast cancer. J Med Internet Res. 2012 Jul 11; 14(4):e97. Cohen E, Belkora J, Tyler J, Schreiner J, Deering MJ, Grama L, Duggan B, Illi J, Pederson J, Anand A, Teng A, McCreary E, Moore D, Tripathy D, Hogarth M, Lieberman M, Park J, Esserman L. PMID: 22784878.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    180. Biology of breast cancer in Nigerian women: a pilot study. Ann Afr Med. 2012 Jul-Sep; 11(3):169-75. Adisa CA, Eleweke N, Alfred AA, Campbell MJ, Sharma R, Nseyo O, Tandon V, Mukhtar R, Greninger A, Risi JD, Esserman LJ. PMID: 22684136.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    181. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012 Jun 10; 486(7403):353-60. Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Leitch M, Hunt K, Olson J, Tao Y, Maher CA, Fulton LL, Fulton RS, Harrison M, Oberkfell B, Du F, Demeter R, Vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang LW, Bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ER. PMID: 22722193.
      View in: PubMed   Mentions: 404     Fields:    Translation:HumansCells
    182. A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints. Lancet Oncol. 2012 Jun; 13(6):e240-8. Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart M. PMID: 22652232.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    183. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology. 2012 Jun; 263(3):663-72. Hylton NM, Blume JD, Bernreuter WK, Pisano ED, Rosen MA, Morris EA, Weatherall PT, Lehman CD, Newstead GM, Polin S, Marques HS, Esserman LJ, Schnall MD. PMID: 22623692.
      View in: PubMed   Mentions: 112     Fields:    Translation:Humans
    184. The effects of acellular dermal matrix in expander-implant breast reconstruction after total skin-sparing mastectomy: results of a prospective practice improvement study. Plast Reconstr Surg. 2012 Jun; 129(6):901e-908e. Peled AW, Foster RD, Garwood ER, Moore DH, Ewing CA, Alvarado M, Hwang ES, Esserman LJ. PMID: 22634688.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    185. Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomy. Ann Surg. 2012 Jun; 255(6):1151-7. Chang EI, Peled AW, Foster RD, Lin C, Zeidler KR, Ewing CA, Alvarado M, Hwang ES, Esserman LJ. PMID: 22470069.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    186. Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657. J Clin Oncol. 2012 Sep 10; 30(26):3242-9. Esserman LJ, Berry DA, DeMichele A, Carey L, Davis SE, Buxton M, Hudis C, Gray JW, Perou C, Yau C, Livasy C, Krontiras H, Montgomery L, Tripathy D, Lehman C, Liu MC, Olopade OI, Rugo HS, Carpenter JT, Dressler L, Chhieng D, Singh B, Mies C, Rabban J, Chen YY, Giri D, van 't Veer L, Hylton N. PMID: 22649152.
      View in: PubMed   Mentions: 128     Fields:    Translation:Humans
    187. Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer. Ann Surg Oncol. 2012 Nov; 19(12):3979-86. Mukhtar RA, Moore AP, Tandon VJ, Nseyo O, Twomey P, Adisa CA, Eleweke N, Au A, Baehner FL, Moore DH, McGrath MS, Olopade OI, Gray JW, Campbell MJ, Esserman LJ. PMID: 22622474.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    188. Breast cancer recurrence is dictated by high-risk biology, not choice of surgery. Oncology (Williston Park). 2012 May 15; 26(5). Esserman LJ. PMID: 25192138.
      View in: PubMed   Mentions:    Fields:    
    189. Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts. Ann Surg Oncol. 2012 Oct; 19(11):3402-9. Warren Peled A, Foster RD, Stover AC, Itakura K, Ewing CA, Alvarado M, Hwang ES, Esserman LJ. PMID: 22526909.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    190. MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition. J Exp Med. 2012 Apr 09; 209(4):679-96. Horiuchi D, Kusdra L, Huskey NE, Chandriani S, Lenburg ME, Gonzalez-Angulo AM, Creasman KJ, Bazarov AV, Smyth JW, Davis SE, Yaswen P, Mills GB, Esserman LJ, Goga A. PMID: 22430491.
      View in: PubMed   Mentions: 111     Fields:    Translation:HumansAnimalsCells
    191. Overdiagnosis and overtreatment of breast cancer. Am Soc Clin Oncol Educ Book. 2012; e40-5. Alvarado M, Ozanne E, Esserman L. PMID: 24451829.
      View in: PubMed   Mentions: 14     Fields:    
    192. Targeting Molecular Aberrations in Breast Cancer: Is It about Time? Am Soc Clin Oncol Educ Book. 2012; 186-91. Esserman L, Benz C, Demichele A. PMID: 24451732.
      View in: PubMed   Mentions:    Fields:    
    193. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657). Breast Cancer Res Treat. 2012 Apr; 132(3):1049-62. Esserman LJ, Berry DA, Cheang MC, Yau C, Perou CM, Carey L, DeMichele A, Gray JW, Conway-Dorsey K, Lenburg ME, Buxton MB, Davis SE, van't Veer LJ, Hudis C, Chin K, Wolf D, Krontiras H, Montgomery L, Tripathy D, Lehman C, Liu MC, Olopade OI, Rugo HS, Carpenter JT, Livasy C, Dressler L, Chhieng D, Singh B, Mies C, Rabban J, Chen YY, Giri D, Au A, Hylton N. PMID: 22198468.
      View in: PubMed   Mentions: 130     Fields:    Translation:Humans
    194. Accelerating identification and regulatory approval of investigational cancer drugs. JAMA. 2011 Dec 21; 306(23):2608-9. Esserman LJ, Woodcock J. PMID: 22187281.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    195. Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen types. Lancet Oncol. 2011 Nov; 12(12):1162-8. Loi S, Symmans WF, Bartlett JM, Fumagalli D, Van't Veer L, Forbes JF, Bedard P, Denkert C, Zujewski J, Viale G, Pusztai L, Esserman LJ, Leyland-Jones BR. PMID: 21684810.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    196. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat. 2011 Dec; 130(3):725-34. Esserman LJ, Shieh Y, Rutgers EJ, Knauer M, Retèl VP, Mook S, Glas AM, Moore DH, Linn S, van Leeuwen FE, van 't Veer LJ. PMID: 21892702.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    197. Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Breast. 2011 Dec; 20(6):529-33. Meyerson AF, Lessing JN, Itakura K, Hylton NM, Wolverton DE, Joe BN, Esserman LJ, Hwang ES. PMID: 21843942.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    198. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8):2796-801. Ruffell B, Au A, Rugo HS, Esserman LJ, Hwang ES, Coussens LM. PMID: 21825174.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansCells
    199. Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial). Breast Cancer Res Treat. 2012 Apr; 132(3):871-9. Lin C, Buxton MB, Moore D, Krontiras H, Carey L, DeMichele A, Montgomery L, Tripathy D, Lehman C, Liu M, Olapade O, Yau C, Berry D, Esserman LJ. PMID: 21796368.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    200. Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat. 2011 Nov; 130(2):635-44. Mukhtar RA, Moore AP, Nseyo O, Baehner FL, Au A, Moore DH, Twomey P, Campbell MJ, Esserman LJ. PMID: 21717106.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    201. Biologic markers determine both the risk and the timing of recurrence in breast cancer. Breast Cancer Res Treat. 2011 Sep; 129(2):607-16. Esserman LJ, Moore DH, Tsing PJ, Chu PW, Yau C, Ozanne E, Chung RE, Tandon VJ, Park JW, Baehner FL, Kreps S, Tutt AN, Gillett CE, Benz CC. PMID: 21597921.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    202. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011 May 11; 305(18):1873-81. Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, Chacón JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O'Shaughnessy J, Hortobagyi GN, Symmans WF. PMID: 21558518.
      View in: PubMed   Mentions: 235     Fields:    Translation:Humans
    203. Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol. 2011 Jun 10; 29(17):2342-9. Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JA. PMID: 21555689.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCTClinical Trials
    204. Characterizing the impact of 25 years of DCIS treatment. Breast Cancer Res Treat. 2011 Aug; 129(1):165-73. Ozanne EM, Shieh Y, Barnes J, Bouzan C, Hwang ES, Esserman LJ. PMID: 21390494.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansPHPublic Health
    205. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ. Clin Breast Cancer. 2011 Mar; 11(1):33-8. Itakura K, Lessing J, Sakata T, Heinzerling A, Vriens E, Wisner D, Alvarado M, Esserman L, Ewing C, Hylton N, Hwang ES. PMID: 21421520.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    206. Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics. Expert Rev Mol Diagn. 2011 Jan; 11(1):91-100. Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ. PMID: 21171924.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimalsCells
    207. A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer. Breast Cancer Res. 2010; 12(5):R85. Yau C, Esserman L, Moore DH, Waldman F, Sninsky J, Benz CC. PMID: 20946665.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    208. The Communication and Care Plan: a novel approach to patient-centered clinical information systems. J Biomed Inform. 2010 Oct; 43(5 Suppl):S6-8. Hogarth M, Hajopoulos K, Young M, Cowles N, Churin J, Hornthal B, Esserman L. PMID: 20937486.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    209. Long-term prognostic role of functional limitations among women with breast cancer. J Natl Cancer Inst. 2010 Oct 06; 102(19):1468-77. Braithwaite D, Satariano WA, Sternfeld B, Hiatt RA, Ganz PA, Kerlikowske K, Moore DH, Slattery ML, Tammemagi M, Castillo A, Melisko M, Esserman L, Weltzien EK, Caan BJ. PMID: 20861456.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    210. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Cancer Res Treat. 2011 Aug; 128(3):703-711. Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, Olopade OI, Esserman LJ. PMID: 20842526.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    211. Intraoperative frozen section analysis of sentinel lymph nodes in breast cancer patients: a meta-analysis and single-institution experience. Cancer. 2011 Jan 15; 117(2):250-8. Liu LC, Lang JE, Lu Y, Roe D, Hwang SE, Ewing CA, Esserman LJ, Morita E, Treseler P, Leong SP. PMID: 20818649.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    212. Impact of chemotherapy on postoperative complications after mastectomy and immediate breast reconstruction. Arch Surg. 2010 Sep; 145(9):880-5. Warren Peled A, Itakura K, Foster RD, Hamolsky D, Tanaka J, Ewing C, Alvarado M, Esserman LJ, Hwang ES. PMID: 20855759.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    213. Lessons learned from genetic testing. JAMA. 2010 Sep 01; 304(9):1011-2. Esserman L, Kaklamani V. PMID: 20810382.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    214. Expanding the reach of decision and communication aids in a breast care center: a quality improvement study. Patient Educ Couns. 2011 May; 83(2):234-9. Belkora JK, Teng A, Volz S, Loth MK, Esserman LJ. PMID: 20696543.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    215. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010 Jul 10; 376(9735):91-102. Vaidya JS, Joseph DJ, Tobias JS, Bulsara M, Wenz F, Saunders C, Alvarado M, Flyger HL, Massarut S, Eiermann W, Keshtgar M, Dewar J, Kraus-Tiefenbacher U, Sütterlin M, Esserman L, Holtveg HM, Roncadin M, Pigorsch S, Metaxas M, Falzon M, Matthews A, Corica T, Williams NR, Baum M. PMID: 20570343.
      View in: PubMed   Mentions: 167     Fields:    Translation:HumansCTClinical Trials
    216. Is radiation indicated in patients with ductal carcinoma in situ and close or positive mastectomy margins? Int J Radiat Oncol Biol Phys. 2011 May 01; 80(1):25-30. Chan LW, Rabban J, Hwang ES, Bevan A, Alvarado M, Ewing C, Esserman L, Fowble B. PMID: 20646871.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    217. Solving the overdiagnosis dilemma. J Natl Cancer Inst. 2010 May 05; 102(9):582-3. Esserman L, Thompson I. PMID: 20413743.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    218. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010 Jan; 119(1):137-44. Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, Flowers CI, Garber J, Lesnikoski BA, Hwang ES, Olopade O, Port ER, Campbell M, Esserman LJ. PMID: 19728082.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    219. Application of screening principles to the reconstructed breast. J Clin Oncol. 2010 Jan 01; 28(1):173-80. Zakhireh J, Fowble B, Esserman LJ. PMID: 19884555.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    220. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009 Oct 21; 302(15):1685-92. Esserman L, Shieh Y, Thompson I. PMID: 19843904.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansPHPublic Health
    221. Bacteriologic features of surgical site infections following breast surgery. Am J Surg. 2009 Oct; 198(4):529-31. Mukhtar RA, Throckmorton AD, Alvarado MD, Ewing CA, Esserman LJ, Chiu C, Hwang ES. PMID: 19800462.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    222. Pathologic and biologic response to preoperative endocrine therapy in patients with ER-positive ductal carcinoma in situ. BMC Cancer. 2009 Aug 18; 9:285. Chen YY, DeVries S, Anderson J, Lessing J, Swain R, Chin K, Shim V, Esserman LJ, Waldman FM, Hwang ES. PMID: 19689789.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    223. A comparison of RNA amplification techniques at sub-nanogram input concentration. BMC Genomics. 2009 Jul 20; 10:326. Lang JE, Magbanua MJ, Scott JH, Makrigiorgos GM, Wang G, Federman S, Esserman LJ, Park JW, Haqq CM. PMID: 19619282.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    224. I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther. 2009 Jul; 86(1):97-100. Barker AD, Sigman CC, Kelloff GJ, Hylton NM, Berry DA, Esserman LJ. PMID: 19440188.
      View in: PubMed   Mentions: 179     Fields:    Translation:Humans
    225. Improved surgical outcomes for breast cancer patients receiving neoadjuvant aromatase inhibitor therapy: results from a multicenter phase II trial. J Am Coll Surg. 2009 May; 208(5):906-14; discussion 915-6. Olson JA, Budd GT, Carey LA, Harris LA, Esserman LJ, Fleming GF, Marcom PK, Leight GS, Giuntoli T, Commean P, Bae K, Luo J, Ellis MJ. PMID: 19476859.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCTClinical Trials
    226. Prognostic implications of positive nonsentinel lymph nodes removed during selective sentinel lymphadenectomy for breast cancer. Breast J. 2009 May-Jun; 15(3):242-6. Lang JE, Liu LC, Lu Y, Jenkins T, Hwang SE, Esserman LJ, Ewing CA, Alvarado M, Morita E, Treseler P, Leong SP. PMID: 19645778.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    227. Oncologist use of the Adjuvant! model for risk communication: a pilot study examining patient knowledge of 10-year prognosis. BMC Cancer. 2009 Apr 28; 9:127. Belkora JK, Rugo HS, Moore DH, Hutton DW, Chen DF, Esserman LJ. PMID: 19400938.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    228. The UCSC Cancer Genomics Browser. Nat Methods. 2009 Apr; 6(4):239-40. Zhu J, Sanborn JZ, Benz S, Szeto C, Hsu F, Kuhn RM, Karolchik D, Archie J, Lenburg ME, Esserman LJ, Kent WJ, Haussler D, Wang T. PMID: 19333237.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    229. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int J Cancer. 2009 Mar 01; 124(5):1213-9. Braithwaite D, Tammemagi CM, Moore DH, Ozanne EM, Hiatt RA, Belkora J, West DW, Satariano WA, Liebman M, Esserman L. PMID: 19058216.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    230. Total skin-sparing mastectomy: complications and local recurrence rates in 2 cohorts of patients. Ann Surg. 2009 Jan; 249(1):26-32. Garwood ER, Moore D, Ewing C, Hwang ES, Alvarado M, Foster RD, Esserman LJ. PMID: 19106672.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    231. When informed, all women do not prefer breast conservation. J Clin Oncol. 2009 Feb 01; 27(4):484-6. Throckmorton AD, Esserman LJ. PMID: 19114690.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    232. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. J Clin Oncol. 2009 Jan 10; 27(2):214-9. Ozanne EM, Braithwaite D, Sepucha K, Moore D, Esserman L, Belkora J. PMID: 19047286.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    233. Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature. BMC Cancer. 2008 Nov 21; 8:339. Tutt A, Wang A, Rowland C, Gillett C, Lau K, Chew K, Dai H, Kwok S, Ryder K, Shu H, Springall R, Cane P, McCallie B, Kam-Morgan L, Anderson S, Buerger H, Gray J, Bennington J, Esserman L, Hastie T, Broder S, Sninsky J, Brandt B, Waldman F. PMID: 19025599.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    234. Converting evidence to practice: a guide for the clinical application of MRI for the screening and management of breast cancer. Eur J Cancer. 2008 Dec; 44(18):2742-52. Zakhireh J, Gomez R, Esserman L. PMID: 18977653.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    235. Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer? J Am Coll Surg. 2008 Dec; 207(6):853-8. Liu LC, Lang JE, Jenkins T, Lu Y, Ewing CA, Hwang SE, Sokol S, Alvarado M, Esserman LJ, Morita E, Treseler P, Leong SP. PMID: 19183531.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    236. Monitoring the implementation of Consultation Planning, Recording, and Summarizing in a breast care center. Patient Educ Couns. 2008 Dec; 73(3):536-43. Belkora JK, Loth MK, Chen DF, Chen JY, Volz S, Esserman LJ. PMID: 18755564.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    237. Risk communication with patients with breast cancer: cautionary notes about printing Adjuvant! estimates. Lancet Oncol. 2008 Jul; 9(7):602-3. Belkora J, Rugo HS, Moore DH, Hutton D, Esserman L. PMID: 18598923.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    238. Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology. 2008 Jul; 248(1):79-87. Li KL, Partridge SC, Joe BN, Gibbs JE, Lu Y, Esserman LJ, Hylton NM. PMID: 18566170.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    239. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users. Cancer Epidemiol Biomarkers Prev. 2008 May; 17(5):1028-33. Kumar AS, Benz CC, Shim V, Minami CA, Moore DH, Esserman LJ. PMID: 18463402.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    240. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol. 2008 Feb 10; 26(5):791-7. Buchholz TA, Lehman CD, Harris JR, Pockaj BA, Khouri N, Hylton NF, Miller MJ, Whelan T, Pierce LJ, Esserman LJ, Newman LA, Smith BL, Bear HD, Mamounas EP. PMID: 18258988.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    241. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res. 2008 Apr; 7(4):1508-17. Wulfkuhle JD, Speer R, Pierobon M, Laird J, Espina V, Deng J, Mammano E, Yang SX, Swain SM, Nitti D, Esserman LJ, Belluco C, Liotta LA, Petricoin EF. PMID: 18257519.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCells
    242. Training community resource center and clinic personnel to prompt patients in listing questions for doctors: follow-up interviews about barriers and facilitators to the implementation of consultation planning. Implement Sci. 2008 Jan 31; 3:6. Belkora J, Edlow B, Aviv C, Sepucha K, Esserman L. PMID: 18237380.
      View in: PubMed   Mentions: 8     Fields:    
    243. Optimizing the total skin-sparing mastectomy. Arch Surg. 2008 Jan; 143(1):38-45; discussion 45. Wijayanayagam A, Kumar AS, Foster RD, Esserman LJ. PMID: 18209151.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    244. A role for biomarkers in the screening and diagnosis of breast cancer in younger women. Expert Rev Mol Diagn. 2007 Sep; 7(5):533-44. Esserman LJ, Shieh Y, Park JW, Ozanne EM. PMID: 17892362.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    245. Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer. J Clin Oncol. 2007 Aug 20; 25(24):3680-7. Park JW, Melisko ME, Esserman LJ, Jones LA, Wollan JB, Sims R. PMID: 17704416.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    246. Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer. Cancer. 2007 Jun 25; 111(3):185-91. Adduci KM, Annis CE, DeVries S, Chew KL, Boutin J, Magrane G, Ljung BM, Waldman FM, Esserman LJ. PMID: 17474121.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    247. Pilot trial of a computerized decision aid for breast cancer prevention. Breast J. 2007 Mar-Apr; 13(2):147-54. Ozanne EM, Annis C, Adduci K, Showstack J, Esserman L. PMID: 17319855.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    248. Ductal carcinoma in situ in BRCA mutation carriers. J Clin Oncol. 2007 Feb 20; 25(6):642-7. Hwang ES, McLennan JL, Moore DH, Crawford BB, Esserman LJ, Ziegler JL. PMID: 17210933.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    249. Analysis of molecular inversion probe performance for allele copy number determination. Genome Biol. 2007; 8(11):R246. Wang Y, Moorhead M, Karlin-Neumann G, Wang NJ, Ireland J, Lin S, Chen C, Heiser LM, Chin K, Esserman L, Gray JW, Spellman PT, Faham M. PMID: 18028543.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    250. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006 Dec; 10(6):529-41. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C, Dairkee S, Meng Z, Chew K, Pinkel D, Jain A, Ljung BM, Esserman L, Albertson DG, Waldman FM, Gray JW. PMID: 17157792.
      View in: PubMed   Mentions: 512     Fields:    Translation:HumansCells
    251. Type and duration of exogenous hormone use affects breast cancer histology. Ann Surg Oncol. 2007 Feb; 14(2):695-703. Kumar AS, Cureton E, Shim V, Sakata T, Moore DH, Benz CC, Esserman LJ, Hwang ES. PMID: 17103262.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    252. Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol. 2006 Oct 01; 24(28):4603-10. Esserman LJ, Kumar AS, Herrera AF, Leung J, Au A, Chen YY, Moore DH, Chen DF, Hellawell J, Wolverton D, Hwang ES, Hylton NM. PMID: 17008702.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    253. Biologic significance of false-positive magnetic resonance imaging enhancement in the setting of ductal carcinoma in situ. Am J Surg. 2006 Oct; 192(4):520-4. Kumar AS, Chen DF, Au A, Chen YY, Leung J, Garwood ER, Gibbs J, Hylton N, Esserman LJ. PMID: 16978965.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    254. Breast cancer growth prevention by statins. Cancer Res. 2006 Sep 01; 66(17):8707-14. Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, Baehner F, Kumar AS, Adduci K, Marx C, Petricoin EF, Liotta LA, Winters M, Benz S, Benz CC. PMID: 16951186.
      View in: PubMed   Mentions: 113     Fields:    Translation:HumansCells
    255. Evaluation of a visit preparation intervention implemented in two rural, underserved counties of Northern California. Patient Educ Couns. 2006 Dec; 64(1-3):350-9. Belkora J, Katapodi M, Moore D, Franklin L, Hopper K, Esserman L. PMID: 16904859.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    256. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice. Cancer Gene Ther. 2006 Nov; 13(11):1002-10. Jabrane-Ferrat N, Campbell MJ, Esserman LJ, Peterlin BM. PMID: 16841083.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    257. Clinical trials are required to prove the chemopreventive worth of statins. Arch Intern Med. 2006 May 22; 166(10):1143; author reply 1144. Kumar AS, Benz CC, Esserman LJ. PMID: 16717179.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    258. A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes. J Clin Oncol. 2006 May 01; 24(13):2127; author reply 2127-8. Kumar AS, Campbell M, Benz CC, Esserman LJ. PMID: 16648516.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    259. Mammographic, sonographic, and pathologic characteristics of Burkitt's lymphoma in a patient referred for diagnostic mammography. AJR Am J Roentgenol. 2006 Apr; 186(4):1029-32. Esserman L, Sexton R, Yu QQ, Cabello-Inchausti B. PMID: 16554574.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    260. Breast cancer risk assessment and prevention: a framework for shared decision-making consultations. Breast J. 2006 Mar-Apr; 12(2):103-13. Ozanne EM, Klemp JR, Esserman LJ. PMID: 16509834.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    261. Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2006 Feb; 4(2):156-76. Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN. PMID: 16451772.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    262. Statins: health-promoting agents show promise for breast cancer prevention. Clin Breast Cancer. 2005 Dec; 6(5):455-9. Kumar AS, Esserman LJ. PMID: 16381630.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    263. Tamoxifen may prevent both ER+ and ER- breast cancers and select for ER- carcinogenesis: an alternative hypothesis. Breast Cancer Res. 2005; 7(6):R1153-8. Esserman LJ, Ozanne EM, Dowsett M, Slingerland JM. PMID: 16457695.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    264. Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA. 2005 Oct 19; 294(15):1925-33. Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI. PMID: 16234499.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    265. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J. 2005 Sep-Oct; 11(5):338-43. Tan YY, Wu CT, Fan YG, Hwang S, Ewing C, Lane K, Esserman L, Lu Y, Treseler P, Morita E, Leong SP. PMID: 16174155.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    266. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol. 2005 Sep; 12(9):705-11. Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP. PMID: 16079953.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    267. Ratio of positive to total number of sentinel nodes predicts nonsentinel node status in breast cancer patients. Breast J. 2005 Jul-Aug; 11(4):248-53. Tan YY, Fan YG, Lu Y, Hwang S, Ewing C, Esserman L, Morita E, Treseler P, Leong SP. PMID: 15982390.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    268. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol. 2005 Jun; 184(6):1774-81. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Tripathy D, Wolverton DS, Rugo HS, Hwang ES, Ewing CA, Hylton NM. PMID: 15908529.
      View in: PubMed   Mentions: 82     Fields:    Translation:Humans
    269. Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy. J Clin Oncol. 2005 May 20; 23(15):3614-21. Petricoin EF, Bichsel VE, Calvert VS, Espina V, Winters M, Young L, Belluco C, Trock BJ, Lippman M, Fishman DA, Sgroi DC, Munson PJ, Esserman LJ, Liotta LA. PMID: 15908672.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    270. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res Treat. 2005 May; 91(2):163-71. Campbell MJ, Scott J, Maecker HT, Park JW, Esserman LJ. PMID: 15868444.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    271. Integration of imaging in the management of breast cancer. J Clin Oncol. 2005 Mar 10; 23(8):1601-2. Esserman L. PMID: 15755961.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    272. Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease. Arch Surg. 2005 Feb; 140(2):196-8; discussion 199-200. Foster RD, Hansen SL, Esserman LJ, Hwang ES, Ewing C, Lane K, Anthony JP. PMID: 15724003.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    273. Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans. Breast Cancer Res Treat. 2005 Feb; 89(3):257-64. Misell LM, Hwang ES, Au A, Esserman L, Hellerstein MK. PMID: 15754124.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    274. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J. 2005 Jan-Feb; 11(1):29-33. Park C, Seid P, Morita E, Iwanaga K, Weinberg V, Quivey J, Hwang ES, Esserman LJ, Leong SP. PMID: 15647075.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    275. Recruitment, genetic counseling, and BRCA testing for underserved women at a public hospital. Genet Test. 2005; 9(4):306-12. Lee R, Beattie M, Crawford B, Mak J, Stewart N, Komaromy M, Esserman L, Shaw L, McLennan J, Strachowski L, Luce J, Ziegler J. PMID: 16379544.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    276. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg. 2004 Dec; 199(6):856-62. Lang JE, Esserman LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, Hwang ES. PMID: 15555967.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    277. Evaluation of breast cancer risk assessment techniques: a cost-effectiveness analysis. Cancer Epidemiol Biomarkers Prev. 2004 Dec; 13(12):2043-52. Ozanne EM, Esserman LJ. PMID: 15598759.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    278. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer. 2004 Jun 15; 100(12):2562-72. Hwang ES, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, Esserman LJ, Waldman FM. PMID: 15197797.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    279. Neoadjuvant chemotherapy for primary breast cancer: lessons learned and opportunities to optimize therapy. Ann Surg Oncol. 2004 Jan; 11(1 Suppl):3S-8S. Esserman L. PMID: 15015703.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    280. Applying the neoadjuvant paradigm to ductal carcinoma in situ. Ann Surg Oncol. 2004 Jan; 11(1 Suppl):28S-36S. Esserman L, Sepucha K, Ozanne E, Hwang ES. PMID: 15015707.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    281. Neoadjuvant hormonal therapy for ductal carcinoma in situ: trial design and preliminary results. Ann Surg Oncol. 2004 Jan; 11(1 Suppl):37S-43S. Hwang ES, Esserman L. PMID: 15015708.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    282. An XML message broker framework for exchange and integration of microarray data. Bioinformatics. 2003 Sep 22; 19(14):1844-5. Tjandra D, Wong S, Shen W, Pulliam B, Yu E, Esserman L. PMID: 14512357.
      View in: PubMed   Mentions:    Fields:    
    283. Racial differences in mammographic breast density. Cancer. 2003 Aug 01; 98(3):590-6. del Carmen MG, Hughes KS, Halpern E, Rafferty E, Kopans D, Parisky YR, Sardi A, Esserman L, Rust S, Michaelson J. PMID: 12879477.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    284. Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium. Cancer Res. 2003 May 15; 63(10):2347-50. Shim V, Gauthier ML, Sudilovsky D, Mantei K, Chew KL, Moore DH, Cha I, Tlsty TD, Esserman LJ. PMID: 12750248.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    285. Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol. 2003 May; 10(4):381-8. Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM. PMID: 12734086.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    286. MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators? Int Immunol. 2003 Apr; 15(4):467-75. Jabrane-Ferrat N, Nekrep N, Tosi G, Esserman L, Peterlin BM. PMID: 12663676.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    287. Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients. Breast J. 2003 Mar-Apr; 9(2):86-90. Wu CT, Morita ET, Treseler PA, Esserman LJ, Hwang ES, Kuerer HM, Santos CL, Leong SP. PMID: 12603380.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    288. Improving the quality of decision making in breast cancer: consultation planning template and consultation recording template. Oncol Nurs Forum. 2003 Jan-Feb; 30(1):99-106. Sepucha KR, Belkora JK, Aviv C, Mutchnik S, Esserman LJ. PMID: 12515987.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    289. Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions. AJR Am J Roentgenol. 2003 Jan; 180(1):263-9. Parisky YR, Sardi A, Hamm R, Hughes K, Esserman L, Rust S, Callahan K. PMID: 12490517.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    290. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol. 2002 Nov; 179(5):1193-9. Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. PMID: 12388497.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    291. Axillary metastasis from a malignant mullerian mixed tumor. Breast J. 2002 Sep-Oct; 8(5):305-6. Cura MA, Blanco M, Esserman L. PMID: 12199759.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    292. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers. Mol Cell Biol. 2002 Aug; 22(15):5616-25. Jabrane-Ferrat N, Nekrep N, Tosi G, Esserman LJ, Peterlin BM. PMID: 12101253.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    293. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. J Natl Cancer Inst. 2002 Jun 05; 94(11):844-51. Euhus DM, Smith KC, Robinson L, Stucky A, Olopade OI, Cummings S, Garber JE, Chittenden A, Mills GB, Rieger P, Esserman L, Crawford B, Hughes KS, Roche CA, Ganz PA, Seldon J, Fabian CJ, Klemp J, Tomlinson G. PMID: 12048272.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    294. Magnetic resonance imaging for primary breast cancer management: current role and new applications. Endocr Relat Cancer. 2002 Jun; 9(2):141-53. Esserman L, Wolverton D, Hylton N. PMID: 12121836.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    295. Epithelial and fibroblast cell lines derived from a spontaneous mammary carcinoma in a MMTV/neu transgenic mouse. In Vitro Cell Dev Biol Anim. 2002 Jun; 38(6):326-33. Campbell MJ, Wollish WS, Lobo M, Esserman LJ. PMID: 12513120.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    296. Skin-sparing mastectomy and immediate breast reconstruction: a prospective cohort study for the treatment of advanced stages of breast carcinoma. Ann Surg Oncol. 2002 Jun; 9(5):462-6. Foster RD, Esserman LJ, Anthony JP, Hwang ES, Do H. PMID: 12052757.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    297. Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians. J Clin Oncol. 2002 Jun 01; 20(11):2695-700. Sepucha KR, Belkora JK, Mutchnick S, Esserman LJ. PMID: 12039932.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    298. New approaches to the imaging, diagnosis, and biopsy of breast lesions. Cancer J. 2002 May-Jun; 8 Suppl 1:S1-14. Esserman LJ. PMID: 12075695.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    299. Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst. 2002 Mar 06; 94(5):369-75. Esserman L, Cowley H, Eberle C, Kirkpatrick A, Chang S, Berbaum K, Gale A. PMID: 11880475.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansPHPublic Health
    300. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst. 2001 Nov 07; 93(21):1624-32. Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB. PMID: 11698566.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    301. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol. 2001 Jul; 8(6):549-59. Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, Hylton N. PMID: 11456056.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    302. The impact of alternative practices on the cost and quality of mammographic screening in the United States. Clin Breast Cancer. 2001 Jul; 2(2):145-52. Burnside E, Belkora J, Esserman L. PMID: 11899786.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    303. Does timely assessment affect the anxiety associated with an abnormal mammogram result? J Womens Health Gend Based Med. 2001 Jul-Aug; 10(6):599-605. Haas J, Kaplan C, McMillan A, Esserman LJ. PMID: 11559457.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    304. Ductal growth is impeded in mammary glands of C-neu transgenic mice. Oncogene. 2000 Dec 07; 19(52):5982-7. Mukherjee S, Louie SG, Campbell M, Esserman L, Shyamala G. PMID: 11146549.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    305. MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. AJR Am J Roentgenol. 2000 Dec; 175(6):1577-84. Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM. PMID: 11090379.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    306. Integration of breast imaging into cancer management. Curr Oncol Rep. 2000 Nov; 2(6):572-81. Esserman LJ, Wolverton D, Hylton N. PMID: 11122895.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    307. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR Am J Roentgenol. 2000 Jul; 175(1):35-43. Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM. PMID: 10882243.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    308. Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery. Ann Surg Oncol. 2000 Jun; 7(5):325-32. Kuerer HM, Hwang ES, Anthony JP, Dudley RA, Crawford B, Aubry WM, Esserman LJ. PMID: 10864338.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    309. Building bridges between physicians and patients: results of a pilot study examining new tools for collaborative decision making in breast cancer. J Clin Oncol. 2000 Mar; 18(6):1230-8. Sepucha KR, Belkora JK, Tripathy D, Esserman LJ. PMID: 10715292.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    310. Management of ductal carcinoma in situ. Surg Clin North Am. 1999 Oct; 79(5):1007-30, viii. Hwang ES, Esserman LJ. PMID: 10572548.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    311. Biological therapies for breast carcinoma: concepts for improvement in survival. Semin Oncol. 1999 Aug; 26(4 Suppl 12):28-40. Borden EC, Esserman L, Linder DJ, Campbell MJ, Fulton AM. PMID: 10482192.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsPHPublic Health
    312. Prophylactic mastectomy in women with a high risk of breast cancer. N Engl J Med. 1999 Jun 10; 340(23):1838; author reply 1839. Kuerer HM, Hwang ES, Esserman LJ. PMID: 10366321.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    313. Vaccination with the extracellular domain of p185neu prevents mammary tumor development in neu transgenic mice. Cancer Immunol Immunother. 1999 Feb; 47(6):337-42. Esserman LJ, Lopez T, Montes R, Bald LN, Fendly BM, Campbell MJ. PMID: 10203064.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    314. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol. 1999 Jan; 17(1):110-9. Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. PMID: 10458224.
      View in: PubMed   Mentions: 69     Fields:    Translation:Humans
    315. Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma. Breast J. 1999 Jan; 5(1):13-21. Esserman L, Hylton N, George T, Weidner N. PMID: 11348250.
      View in: PubMed   Mentions: 37     Fields:    
    316. A multicenter randomized trial of DIAC for cyclical mastopathy. Prim Care Update Ob Gyns. 1998 Jul 01; 5(4):211. Ballagh SA, Stover TL, Maragos TG, Reynolds MD, Wolfley GD, Esserman LJ, Herbst JR, Kirkegaard LW, Teichman SL. PMID: 10838398.
      View in: PubMed   Mentions:
    317. Is routine frozen section assessment feasible in the practice environment of the 1990s? Cancer J Sci Am. 1997 Sep-Oct; 3(5):266-7. Esserman L, Weidner N. PMID: 9327147.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    318. Hormone replacement therapy and breast cancer risk. Cancer Pract. 1997 Jul-Aug; 5(4):203-8. Burke CC, Gullatte MM, Vigliani M, Ruggiero RJ, Esserman L, Crawford B. PMID: 9250076.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    319. Ultrasound tissue characterization of breast biopsy specimens: expanded study. Ultrason Imaging. 1996 Jul; 18(3):215-30. Mortensen CL, Edmonds PD, Gorfu Y, Hill JR, Jensen JF, Schattner P, Shifrin LA, Valdes AD, Jeffrey SS, Esserman LJ. PMID: 9123674.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    320. Barriers to care and treatment: the challenge of daily radiation therapy. Cancer Pract. 1996 Mar-Apr; 4(2):65-7. Igoe S, Collins C, Hamolsky D, Esserman LJ. PMID: 8715442.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    321. Should we recommend screening mammography for women aged 40 to 49? Oncology (Williston Park). 1996 Mar; 10(3):357-64; discussion: 370-6. Esserman L, Kerlikowske K. PMID: 8820449.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    322. Breast. Pathology (Phila). 1996; 3(2):417-26. Weidner N, Esserman LJ. PMID: 8795829.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    323. Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma-in-situ of the breast. J Clin Oncol. 1996 Jan; 14(1):70-7. Hillner BE, Desch CE, Carlson RW, Smith TJ, Esserman L, Bear HD. PMID: 8558224.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    324. Potentially ineffective care. A new outcome to assess the limits of critical care. JAMA. 1995 Nov 15; 274(19):1544-51. Esserman L, Belkora J, Lenert L. PMID: 7474223.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    325. Cost per anomaly: what does a diaphragmatic hernia cost? J Pediatr Surg. 1995 Feb; 30(2):226-30. Metkus AP, Esserman L, Sola A, Harrison MR, Adzick NS. PMID: 7738743.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    326. An epitope on the transferrin receptor preferentially exposed during tumor progression in human lymphoma is close to the ligand binding site. Blood. 1991 Feb 15; 77(4):826-32. Takahashi S, Esserman L, Levy R. PMID: 1704266.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    327. Follicular lymphoma: a model of lymphoid tumor progression in man. Ann Oncol. 1991 Feb; 2 Suppl 2:115-22. Zelenetz AD, Campbell MJ, Bahler DW, Takahashi S, Oren R, Esserman L, Umetsu DT, Kwak LW, Maloney DG, Brown S. PMID: 2049308.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    328. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunity. J Immunol. 1990 Aug 01; 145(3):1029-36. Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. PMID: 2373859.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCellsPHPublic Health
    329. Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumor. Int Rev Immunol. 1989; 4(4):251-70. Campbell MJ, Esserman L, Byars NE, Allison AC, Levy R. PMID: 2519929.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    330. Immunotherapy of established murine B cell lymphoma. Combination of idiotype immunization and cyclophosphamide. J Immunol. 1988 Nov 01; 141(9):3227-33. Campbell MJ, Esserman L, Levy R. PMID: 3049819.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    331. Myocardial performance and extracellular ionized calcium in a severely failing human heart. Ann Intern Med. 1983 May; 98(5 Pt 1):603-6. Ginsburg R, Esserman LJ, Bristow MR. PMID: 6133487.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    332. A novel method for emergency immobilization of the wrist during cross-country skiing. Am J Sports Med. 1980 Jul-Aug; 8(4):285-6. Goldman MP, Esserman LJ, Bausback KN, Camargo CA, Nagel DA. PMID: 7396060.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    Laura's Networks
    Concepts (763)
    Derived automatically from this person's publications.
    _
    Co-Authors (144)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _